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Abstract: 18 
There is increasing evidence for the health benefits of dietary nitrates including lowering blood 19 
pressure and enhancing cardiovascular health. Although commensal oral bacteria play an important 20 
role in converting dietary nitrate to nitrite, very little is known about the potential role of these 21 
bacteria in blood pressure regulation and maintenance of vascular tone. The main purpose of this 22 
review is to present the current evidence on the involvement of the oral microbiome in mediating 23 
the beneficial effects of dietary nitrate on vascular function and to identify sources of inter and 24 
intra-individual differences in bacterial composition. A systematic approach was used to identify 25 
the relevant articles published on PubMed and Web of Science in English from January 1950 until 26 
September 2019 examining the effects of dietary nitrate on oral microbiome composition and 27 
association with blood pressure and vascular tone. To date, only a limited number of studies have 28 
been conducted, with n=9 in humans and n=3 in animals focusing mainly on blood pressure. In 29 
general, elimination of oral bacteria with use of a chlorhexidine based antiseptic mouthwash 30 
reduced the conversion of nitrate to nitrite and was accompanied in some studies by an increase in 31 
blood pressure in normotensive subjects. In conclusion, our findings suggest that oral bacteria may 32 
play an important role in mediating the beneficial effects of nitrate-rich foods on blood pressure. 33 
Further human intervention studies assessing the potential effects of dietary nitrate on oral bacteria 34 
composition and relationship to real time measures of vascular function are needed, particularly in 35 
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Introduction 44 
Cardiovascular diseases (CVDs), including coronary heart disease and stroke, are one of the leading 45 
causes of death globally. In 2017, the World Health Organization (WHO) reported that 18 million 46 
people had died from CVDs worldwide which represents 31% of deaths1. Abnormally raised blood 47 
pressure, defined as greater than 140 (systolic)/90 (diastolic) mmHg, is an independent risk factor 48 
for CVDs and this silent killer is associated with a three-fold higher risk of having a stroke or 49 
developing heart failure2’
3. High blood pressure affects more than 1 in 4 adults in England, around 50 
12.5 million people. However, the prevalence of hypertension appears to differ between sexes, with 51 
31% reported amongst men and 26% amongst women4.  Dysfunction of the endothelium, which 52 
controls vascular tone and strongly associated with hypertension, is now recognised as an early, but 53 
potentially reversible, step in the development of CVDs5. 54 
The control of vascular function is known to be influenced by dietary factors, with nitrate-55 
rich vegetables considered an important modulator6’7’8. This has been demonstrated in many 56 
observational and cohort studies which have shown consumption of nitrate and nitrite-rich foods to 57 
significantly improve cardiovascular health9 such as lowering blood pressure10 in both healthy11 and 58 
hypertensive individuals12, reducing endothelial dysfunction13’14 15’16’17 and inflammation18, 59 
protection from ischemia reperfusion injury19, and improved exercise performance in patients with  60 
heart failure20. A prospective cohort study has also concluded that an increased adherence to a diet 61 
high in nitrate is accompanied by a significant reduction in the risk of suffering both cardiovascular 62 
complications and death due to any cause21. Clinically, nitrate supplementation or use of nitrate as a 63 
medication to increase the bioavailability of nitrite and nitric oxide (NO) can reduce blood 64 
pressure22.  The interest in using dietary nitrates as a treatment for lowering blood pressure is 65 
growing but mechanisms underlying the effects are unclear which limits their current application as 66 
a dietary treatment for hypertension22. Furthermore, there is some evidence to suggest that high 67 
dietary nitrate intakes are associated with negative effects on health, which has led to the 68 
development of the Acceptable Daily Intake (ADI) for nitrate of 3.7 mg/kg body weight/day and for 69 
Page | 4  
 
nitrite of 0.07 mg/kg body weight/day23. The ADI for nitrate is based on the risk of 70 
methaemoglobinaemia commonly known as blue baby syndrome, which can occur following high 71 
nitrate intake in some babies, and can be fatal 24. In addition, some epidemiological studies have 72 
reported an association between dietary nitrite intake and colorectal cancer. However, the weight of 73 
evidence only supports a significant relationship between cancer and red and processed meat25, with  74 
little known about vegetables and drinking water. The nitrate and nitrite within processed meat may 75 
be a contributing factor in the association with cancer, although this needs further confirmation.  76 
Humans are naturally colonised by an array of microorganisms, such as commensal or 77 
symbiotic communities, whose metabolic activity is important for host physiology and health. 78 
Commensal oral bacteria and those residing in the gastrointestinal (GI) tract play an important role 79 
in converting dietary nitrate to nitrite and the potent vasodilator NO26’27’28’29’30’31. Up to 85% of 80 
ingested nitrate is reduced to nitrite by the nitrate-reducing bacteria in the oral cavity32 raising the 81 
salivary nitrite concentration to 1000 times that of plasma28. A cohort study conducted in 281 82 
volunteers found that the high abundance of nitrate reducing bacteria was associated with blood 83 
pressure in normotensive individuals, although this association was not found in those with 84 
hypertension33. To date, very little is known about the role of these oral bacteria in the control of 85 
vascular function, and the variation in composition that exists between individuals. The aim of this 86 
review is to present the current evidence on the potential role of dietary nitrate and the oral 87 
microbiome on vascular function including blood pressure and vascular tone. Important 88 
determinants of the number and composition of the oral bacteria will also be described. However, 89 
the impact of dietary nitrate interventions on vascular function only will not be specifically 90 
addressed in this instance due to the large number of review articles which already exist in this 91 
research area13’14 15’16’17. Before presentation of the methodology and results of the literature 92 
review, we provide a general overview of dietary nitrate sources, the pathways for the conversion of 93 
dietary nitrate and nitrite to NO, location and type of nitrate-reducing bacteria in the oral cavity and 94 
their potential role in regulating vascular tone.  95 
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 96 
Nitrate, nitrite and nitric oxide sources and nitric oxide pathway 97 
NO, the most effective form of nitrate, was first recognised in 1998 as an important signalling 98 
molecule in the cardiovascular system34. NO plays a significant role in virtually all organs in the 99 
body, and higher circulating concentrations are associated with a lower CVD risk35. In additional to 100 
the dietary (exogenous) sources of nitrate and nitrite which leads to the production of nitrite, and 101 
subsequently NO, via the oral bacteria, the body can also derive NO endogenously (figure1).  The 102 
endogenous pathway can occur in a number of different tissues in the body using three forms of NO 103 
synthase (NOS) enzyme, neuronal (nNOS), endothelial (eNOS) and inducible NOS (iNOS). eNOS 104 
was initially discovered in endothelial cells and is important in modulating vascular tone and 105 
upholding endothelial integrity. However, eNOS can also be expressed in various tissues and 106 
requires the presence of oxygen, calcium and calmodulin to be activated36. Within the endothelium, 107 
L-arginine undergoes a 5-electron oxygen dependent oxidation to produce NO and L-citrulline, 108 
catalysed by the synthase enzymes. Five cofactors required by the NOS enzymes are flavin adenine 109 
dinucleotide (FAD), flavin mononucleotide (FMN), tetrahydrobiopterin (BH4), reduced 110 
nicotinamide-adenine dinucleotide phosphate (NADPH) and heme iron28.  Once produced in the 111 
endothelial cell, NO rapidly diffuses to the underlying smooth muscle layer where it mediates blood 112 
vessel vasodilation. Any NO remaining in the circulation is rapidly converted to nitrate by 113 
oxyhaemoglobin or superoxide before it enters the enterosalivary pathway. Therefore, the NO 114 
produced has a relatively short half-life in the order of seconds to minutes37.  115 
 116 
Nitrate metabolism, enterosalivary circulation and gastrointestinal tract 117 
High levels of inorganic nitrate are found in vegetables (such as beetroot and spinach) as well as 118 
drinking water, and these dietary sources accounts for 80% of the daily intake. In contrast, the 119 
intake of dietary nitrite is very low, being approximately 100 times lower38 than that of nitrate 39. 120 
Although the process of re-circulation of nitrates in the body has been known since 1970s, the 121 
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importance of the oral nitrate-reducing bacteria in the enterosalivary circulation has only recently 122 
been recognised27 (Figure 2). The key role these bacteria play in nitrate reduction was supported by 123 
a previous human study in which a significant correlation was found between high abundance of 124 
oral nitrate-reducing bacteria and nitrite level in saliva40.  Nitrate secretion from the salivary glands 125 
leads to a 10 fold rise in salivary nitrate levels41 and this nitrate enriched saliva appears to be a 126 
supportive environment for the growth of the oral bacteria particularly the nitrate-reducing bacteria 127 
on the tongue42.  These bacteria are mostly facultative anaerobes which use nitrate as an alternative 128 
electron acceptor for their respiration43. A symbiotic relationship therefore exists between the oral 129 
commensal bacteria in which they receive nitrate from the host for their own respiration and in 130 
return produce nitrites required by the host42.  This relationship is particularly important for nitrite 131 
bioavailability since humans are unable to complete this process independent of the nitrate-reducing 132 
bacteria, with 80% of nitrates swallowed and present in the stomach produced by the oral 133 
commensals44. Once in the stomach, contact with the gastric acidity leads to the protonation of 134 
nitrites to form nitrous acid (HNO2), which then decomposes into not only NO but also several 135 
other nitrogen oxides45 which have localised benefits on maintaining the gastric mucosa layer46 and  136 
enhancing mucosal blood flow45 which increases the thickness of the mucosal layer47. This process 137 
is referred to as non-enzymatic conversion which does not require bacteria. However, the presence 138 
of Helicobacter pylori can contribute to a more acidic environment within the stomach and increase 139 
non-enzymatic conversion48. Residual nitrates and nitrites are then absorbed in the small intestine 140 
with the half-life of circulating nitrate in the blood stream of around 5-6 hours49. In contrast, plasma 141 
nitrite concentrations start to increase within 15 minutes of nitrate ingestion and reach a peak level 142 
in 2 hours50. A large portion, approximately 70-75% of the plasma nitrate, is excreted in the urine 143 
whereas the remaining 25% is stored in the salivary gland and then recycled in the enterosalivary 144 
pathway51.  145 
The role of the nitrate-reducing bacteria can persist past the oral cavity as most of these 146 
bacteria move into the stomach with both swallowed food and saliva. Limited studies have 147 
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investigated the existence of these bacteria in the stomach and have confirmed that the gastric 148 
acidity is not a germ-free environment52.  Although the gastric pH is below 5, some bacteria species 149 
can tolerate the stomach acidity, with a culture based study reporting Clostridium spp, 150 
Veillonella spp and Lactobacillus spp as the most predominant gastric species53, with 151 
Veillonella spp identified as the most abundant nitrate reducing bacteria43. There are many factors 152 
that can influence gastric acidity such as inflammation and long-term use of proton pump inhibitors. 153 
The pH level has been found to have a positive impact on nitrate and nitrite concentration in the 154 
gastric juice. In a study conducted in 99 patents with dyspepsia, results showed that when the pH 155 
level of gastric mucosal surface increased there was a comparable increase in both nitrate and nitrite 156 
concentrations. Findings from another study conducted in participants with achlorhydria , in which 157 
gastric pH ranged from 6-8, reported three genera of nitrate reducing bacteria: Streptococci and  158 
Neisseriae to be responsible for the nitrite accumulation in the gastric secretions54.  159 
 The small intestine and colon contain many different species of bacteria including both 160 
facultative and obligate anaerobes which are involved in the bioconversion of nitrite to NO, 161 
although they are not necessarily the same as the nitrate reducing bacteria found in the oral cavity55. 162 
A study conducted in germ-free and normal rats has shown that NO can be produced by the bacteria 163 
resident in the small intestine of normal rats, but not in germ free rats56. Furthermore,  two studies 164 
have identified  Lactobacilli, Bifidobacteria56, Escherichia coli and Shigella as the predominant 165 
nitrate reducing bacteria in the large intestine57. However, an in-vitro study which used pure strains 166 
of gut bacteria incubated in agar media with nitrate then nitrite, found that in the presence of nitrite, 167 
both Bifidobacterial and Lactobacilli generated large amounts of NO, up to 5000 parts per billion 168 
(ppb), but only approximately 35 ppb of nitrate58. Interestingly, Sobko et al reported that the NO 169 
formed was being utilised by Escherichia coli and Staphylococcus aureus 46. These authors 170 
speculated that these gut bacteria may consume NO in order to help adapt to their environment in 171 
this in vitro experiment. Therefore, it appears that the presence of NO and other nitrate metabolites 172 
in the large intestine may be dependent on the relevant abundance of these bacteria species and their 173 
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production and utilisation of NO 59. Localised effects of the NO could include altering blood flow 174 
which could potentially increase the uptake of nitrate and nitrite in the proximal small intestine 175 
where the majority are absorbed44. However, the NO level in the GI tract could also be influenced 176 
by other factors such as pH level, inflammation, oxygen tension and the level of dietary nitrate 177 
intake of an individual. Further studies are need to determine the direct effects of nitrate and nitrite 178 
on gut bacteria composition and nitrate metabolism.  179 
 180 
Bacterial nitrate reduction in the oral cavity, composition and location 181 
A continuous flow of saliva, specialized mucosal surfaces and teeth in the human oral cavity 182 
provide a unique microbial habitat for bacteria. Most of these bacteria are found on the dorsum 183 
(surface) of the tongue and around the teeth where a wash of 1 ml of saliva can contain up to 107 – 184 
108  microorganisms44. However, only 700 species have currently been identified44. The majority of 185 
these bacteria shelter in the gingival crevices between teeth which represents a conducive anaerobic 186 
environment. Here, the gingival crevicular fluid bathes the bacteria within a nutritionally rich 187 
medium supporting their proliferation60. In contrast, the smoother surfaces of teeth have much 188 
lower levels of bacteria due to the forces that act on these areas during eating and drinking. 189 
However, the nitrate-reducing bacteria are found predominately on the rear dorsum of tongue, with 190 
a higher proportion of gram-negative bacteria found within the papillae of the tongue compared to 191 
the surface. Some studies have identified the genus and species of these bacteria that can produce 192 
nitrate reductases and nitrite reductases that aid in the production of nitric oxides. These include: 193 
Veillonella atypical  Veillonella  dispar, Actinomyces  eslumdii, A. odontolyticus, Staphylococcus 194 
epidermids, Neisseria flarescens, Haemophilus, Porphyromonas, Rothia mucilaginosa, Rothia 195 
dentocarisa,  Prevotella and Leptotrichia42’43. The two major groups of oral nitrate-reducing 196 
bacteria are the strict anaerobes such as Veillonella atypica and Veillonella dispar and the 197 
facultative anaerobes such as Actinomyces odontolyticus and Rothia mucilaginosa42. Facultative 198 
anaerobes are mostly prevalent on the surface of the tongue, with a study stratifying participants 199 
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according to oral nitrate reduction capacity observing a higher abundance of Streptococcus, 200 
Granulicatella, Prevotella, Neisseria, and Haemophilus on the posterior surface of the tongue 201 
compared to Actinomyces43. Interestingly, although lower in prevalence, Actinomyces have been 202 
reported to be more efficient reducers of dietary nitrates under anaerobic conditions.  203 
 204 
Mechanisms by which bacteria may convert nitrate to nitrite 205 
The three mechanisms through which nitrates are converted to nitrites and other components by 206 
bacteria are denitrification, assimilation and dissimilation. The first process, denitrification, occurs 207 
in the oral cavity under aerobic conditions61 and is also called the respiratory nitrate reduction 208 
process. During microbial respiration, oxygen is replaced by nitrogen oxides as terminal electron 209 
acceptors and ultimately reduces nitrate to nitrous oxide or free nitrogen62. Most of the bacteria 210 
which have genes for respiratory nitrate reductases (nirS and nirK) prefer aerobic conditions63 such 211 
as Rothia spp and Neisseriae spp. However, some denitrification species of bacteria also reside in 212 
anaerobic conditions44 such as Veillonella. The specialised surface of the tongue dorsum therefore 213 
represents a microaerophilic environment which allows denitrification to occur under both aerobic 214 
and anaerobic conditions. In the oral cavity, nitrite (NO2) is initially formed from salivary nitrate 215 
(NO3) by some oral bacteria such as Actinomyces
43 that are considered to possess the nitrate 216 
reductase enzyme (nar) and further converts nitrite to NO through either enzymatic (nir) or non-217 
enzymatic denitrification. The latter process is a well-established step in the gastric environment of 218 
the stomach. NO is then converted to nitrous oxide (N2O) by nitric oxide reductase (nor) and finally 219 
to nitrogen (N2) by nitrous oxide reductase (nos). The nitrogen oxides and enzymes that participate 220 





NO3                 NO2                 NO                 N2O                 N2   
 
nar nir nor nos 
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In the second pathway known as dissimilation, nitrate is reduced to ammonia (NH4+) by 225 
periplasmic nitrate reductase (nap), with the intermediate product being nitrite64. This two-step  226 
process is strictly anaerobic and occurs in the human gut by the facultative anaerobes55.  227 
 228 
 NO3              NO2                   NH4+ 229 
 230 
Assimilation, which occurs predominantly in plants, water and soil65, is the third pathway. Similar 231 
to denitrification, the conversion of nitrate to ammonia occurs but during this pathway, the enzyme 232 
cytoplasmic nitrate reductase (nas) is used65. In this biosynthetic anabolic pathway, nitrite is further 233 
reduced to ammonia, which can then undergo ammonium assimilation by incorporating the amino 234 
acid glutamine44. The assimilation and dissimilation processes are therefore important in the 235 
utilization of nitrates. Nitrifying bacteria (including Nitrobacter, Nitrococcus and Nitrosomonas)66 236 
are responsible for the dissimilation and ammonification of nitrates and oxidises ammonium salts 237 
and nitrites to nitrates in a process called nitrification. It has been hypothesised that this process 238 
might happen in the gut, but to date, this has not been described67. 239 
In humans, nitrate reduction seems to occur either directly, such as in assimilatory nitrate 240 
reduction, or during a series of reactions during respiratory nitrate reduction. Notably, the latter 241 
process needs more than one enzyme for further reduction which is mediated by the bacterial 242 
communities44.  This suggests that nitrate reducing capacity of nitrate-reducing bacteria is related to 243 
the bacterial species, cellular location of enzymes and environmental conditions such as oxygen 244 
level. Therefore, dissimulation would occur more in the gut and denitrification in the oral cavity67. 245 
Although the role of oral bacteria in mediating the beneficial effect of nitrate on vascular function is 246 
poorly understood, this review aims to address this knowledge gap by focussing on studies that used 247 
antibacterial mouthwash and toothpaste to determine the importance of the presence of oral 248 
microbiome on blood pressure and vascular tone.  249 
 250 
nap nrf 
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Methods 251 
A systematic approach was used to identify the relevant human and animal studies which investigated 252 
the role of dietary nitrate and the oral microbiome on blood pressure. PubMed and Web of Science 253 
were used for the literature search which included all relevant articles published in English from 254 
January 1950 until September 2019. There were three stages in the selection process. The 255 
combinations of the key terms used in the search strategy were as follows: (“Nitrate” OR “Nitrite” 256 
OR “Nitric Oxide”) AND (“Oral Bacteria” OR “Oral Microbiom” OR “Nitrate-Reducing Bacteria”) 257 
AND (“Blood Pressure” OR “Hypertension” OR “Cardiovascular” OR “Vascular Function”) AND 258 
(“Mouth Wash” OR “Antiseptic” OR “Antibacterial”). The titles and abstracts of the identified papers 259 
were screened by one member of the review team (HA) who identified potentially relevant papers. 260 
This review was restricted to animal studies and human studies which used antibacterial mouthwash 261 
or toothpaste to determine the effects on oral nitrate reduction on blood pressure and vascular tone. 262 
Only published peer-reviewed literature was considered and ‘grey’ literature such as dissertations, 263 
conference proceedings, reports, letters to editors and other non-peer-reviewed research, was 264 
excluded. After duplicates were removed, the abstract and full papers were screened for eligibility. 265 
In addition, a hand-search of the bibliographies of the articles found from the electronic database 266 
searches was also conducted. An overview of the literature search is shown in Figure 3. 267 
The quality of the included human RCTs and animal studies were assessed for the risk of 268 
bias using the Cochrane risk of bias tool68 for human studies and SYRCLE’s tool69 for animal 269 
studies.  270 
 271 
Results and Discussion 272 
The systematic search identified 160 publications. Of these, 11 relevant publications were included, 273 
with 9 describing studies conducted in humans and 3 in animals.  The risk of bias assessment 274 
summaries for each study are presented in Supplementary Tables 1 and 2, respectively.  Animal 275 
studies will be discussed before studies including human participants. This will be followed by 276 
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discussion of the non-modifiable and modifiable factors affecting intra-individual variability in 277 
number and composition of oral bacteria, with potential mechanisms of action.  278 
 279 
Animal studies 280 
Of the 14 animal studies which have investigated the effect of nitrate on blood pressure, only 3 281 
studies have determined whether oral bacteria are important in mediating the improvements in 282 
blood pressure and endothelial function (Table 2). Formation of bioactive NO takes place within the 283 
gastric environment of the stomach as a result of the enterosalivary circulation of nitrate, as well as 284 
systemically in the blood vessels. In 2009, Petersson and his colleagues70 reported daily mouthwash 285 
treatment for 7 days in rats to attenuate both the gastroprotection provided by NO and the diastolic 286 
blood pressure lowering effect of sodium nitrate. A similar pattern was also evident for the mean 287 
arterial pressure in the rats treated with mouthwash and nitrate, but the lack of an effect in the rats 288 
treated with mouthwash and nitrite suggested that oral bacteria play an important role in the 289 
metabolism of nitrate to NO and mediated vasodilation. Furthermore, these rats also had reduced 290 
oral bacteria suggesting that nitrite could bypass the reduction step by the oral bacteria and was 291 
being reduced in the circulation or within endothelial cells to NO, or via effects on the formation of 292 
the intermediate nitrosothiols70. However, dietary nitrite intake is generally lower than that of 293 
nitrate, and the half-life in plasma shorter (seconds versus hours) which suggests that even if nitrite 294 
directly stimulates NO signalling, the quantity and kinetics of nitrite versus nitrate indicates that the 295 
critical aspect of this mechanism is the reduction of nitrate. Therefore, the role that dietary nitrite 296 
plays in blood pressure lowering may be more limited relative to nitrate. 297 
In agreement, Hyde et al29 also reported a significant reduction in diastolic blood pressure 298 
and increase in plasma nitrite concentrations following the addition of sodium nitrate to drinking 299 
water in male Wistar rats. However, in this study, mouthwash treatment was unable to diminish the 300 
blood pressure lowering effects of the nitrate supplementation. The authors speculated that the 301 
direct application of the chlorhexidine-based mouthwash (Vedco, St. Joseph, MO) to the tongue 302 
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surface using a swab might not have enabled sufficient time for the mouthwash to exert its full 303 
extent on the bacteria relative to mouthspray29. A novel aspect of this longer-term supplementation 304 
study was the focus on the changes in the microbiota composition on the rat tongue in response to 305 
the treatments. Compared with baseline, there was a greater relative abundance of nitrate reducing 306 
bacteria (Haemophilus spp and Steptococcus spp) after 6 days of sodium nitrate consumption, and 307 
of these Haemophilus parainfluenzae has also been identified as 1 of 14 species contributing to 308 
nitrate reduction in the oral cavity of healthy adults. Co-supplementation of mouthwash with nitrate 309 
was found to increase the diversity of the oral bacteria present relative to nitrate intake only, with 310 
increases found in the low abundance taxa such as Enterobacteriaceae, Corynebacterium, and 311 
Morganella. Therefore, the use of mouthwash appeared to disturb the oral microbiome by reducing 312 
the abundance of the normally dominant taxa but not completely to impact nitrate reduction. These 313 
findings suggest that the lower abundance taxa which were evident after mouthwash treatment may 314 
be functionally important in the bioactivation of dietary nitrate. However, the authors did caution 315 
against translating these findings on the oral bacteria composition to humans since the oral human 316 
microbiome has been shown to be more diverse and of a differing composition compared with the 317 
rat29.  318 
The impact of mouthwash on chronic changes in blood pressure in response to nitrate or 319 
nitrite supplementation was further examined by Pinheiro et al71 in both control and hypertensive 320 
rats. After 4 weeks, significant reductions in mean arterial pressure and systolic blood pressure were 321 
evident in both the nitrate and nitrite groups, with concordant increases found in circulating plasma 322 
nitrate and nitrite levels. Interestingly, co-supplementation with mouthwash attenuated the rise in 323 
plasma nitrite levels by 25-30% in both groups but was only found to blunt the blood pressure 324 
lowering effect of nitrate, with little impact found on blood pressure in the mouthwash and nitrite 325 
group. In agreement with Petersson et al70, these findings suggested that anti-hypertensive effects of 326 
nitrite were potentially occurring via non-enzymatic reactions within the gastric environment after 327 
swallowing this ion independently of the enterosalivary pathway and potentially via non-enzymatic 328 
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reactions within the gastric environment after swallowing this anion. Analysis of the endogenously 329 
produced vasodilatory compound S-nitrosothiol and levels of vascular nitrosylation revealed 330 
mouthwash to reduce nitrosylation responses to nitrate only, leading the authors to speculate that S-331 
nitrosylation was an important mediator of the blood pressure lowering effects of both nitrate and 332 
nitrite70’71. Studies have also reported that the foods consumed with dietary nitrites, such as 333 
conjugated fatty acids, are also a target of nitrating species in the stomach leading to the formation 334 
of nitro-fatty acids (such as nitro-conjugated linoleic acid). These electrophiles have been shown to 335 
have anti-hypertensive effects independent of S-nitrosothiols suggesting that they may also play a 336 
role in mediating the effects of nitrate and nitrite on blood pressure 72. Antiseptic mouthwash was 337 
proposed to attenuate the beneficial effects of dietary nitrate intake on blood pressure by reducing 338 
the amount of nitrite formation by the oral bacteria and therefore reaching the stomach, inhibiting 339 
gastric formation of S-nitrosothiols. However, the positive benefits on blood pressure of raised S-340 
nitrosothiols was only found in the antihypertensive rats, supporting previous observations in both 341 
animals and humans that raised blood pressures often show a greater sensitivity to the anti-342 
hypertensive effects of medication and/or dietary modification.  343 
Studies performed in animals may provide useful insights into the mechanisms underlying 344 
the effects of oral bacteria in the bioactivation of nitrate. However, findings in rats and mice need to 345 
be interpreted with caution due to differences in physiology and dependence on nitrate as a source 346 
of NO between organisms. In contrast to humans, rats and mice do not recirculate nitrate in saliva73 347 
and so salivary nitrate concentrations never exceed those levels found in plasma74 and they also 348 
have other nitrate reducing mechanisms that may work in tandem with nitrate reduction by the oral 349 
bacteria to control nitrite and NO level73.   350 
 351 
Human Studies 352 
The publications describing the human studies were divided into those which examined 1) the 353 
association between oral bacteria with nitrate/nitrite levels and/or blood pressure (n=5; Table 2) and 354 
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2) the combined effects of nitrate ingestion and oral bacteria on nitrate/nitrite levels and/or blood 355 
pressure (n=4; Table 3). The role of the oral bacteria in mediating systemic nitrite production after 356 
nitrate intake has been primarily investigated with the use of an antiseptic mouthwash to remove the 357 
bacteria prior to the measurement of the outcomes of interest. The type of mouthwash has been 358 
shown to be important, with the strong antibacterial chlorhexidine-based mouthwash (Corsodyl) 359 
found to be more effective at reducing Veillonella dispar (nitrate reducing bacteria) in the oral 360 
cavity than Listerine (mixture of essential oils), Isodine and Cepacol (antibacterial) in healthy 361 
adults75. In support of these findings, gargling with 10 ml of chlorohexidine mouthwash (Corsodyl) 362 
twice for 1 min was also found to reduce the bacterial count of nitrate reducing bacteria by 363 
approximately 80% and virtually abolish the oral nitrate reducing capacity compared with no 364 
mouthwash in healthy subjects27. Although nitrate accumulated in saliva after ingestion of sodium 365 
nitrate in both studies, a significant reduction in the conversion of salivary nitrate to nitrite after 366 
mouthwash was associated with 30% lower plasma nitrate concentrations at 3 h post-ingestion, 367 
compared with no prior use of mouthwash. In contrast, a randomised cross-over study found an 368 
antibacterial toothpaste to have no effect on salivary or plasma nitrate concentrations in 16 women 369 
after consuming 400 mg of nitrate before brushing their teeth with antibacterial toothpaste (0.3% 370 
triclosan) or toothpaste containing no antibacterial agent76.  The lack of an effect observed with the 371 
antibacterial toothpaste may reflect either the lower prevalence of the nitrate reducing bacteria on 372 
the surface of the teeth, relative to the tongue, or the less efficient removal of the bacteria sheltering 373 
within the gingival crevices between the teeth compared with mouthwash.  374 
 Four studies have determined the impact of mouthwash on changes in oral nitrate reducing 375 
capacity and blood pressure (Table 2). Compared with no mouthwash, Kapil et al41 reported that 376 
using 0.2% chlorhexidine twice daily for 7 days significantly increased systolic and diastolic blood 377 
pressure measured using 3 different techniques (clinic, ambulatory and home measurements) by 378 
approximately 3 and 2 mmHg respectively in 19 healthy normotensive subjects. Interestingly, the 379 
effects of mouthwash treatment on blood pressure was evident after only a single use of the 380 
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chlorhexidine mouthwash and was maintained for the following 6 days. The rise in blood pressure 381 
was significantly correlated with the significant reduction in plasma nitrite levels, with only a trend 382 
for a relationship with the salivary nitrite, highlighting the potential importance of the oral nitrate-383 
reducing bacteria in blood pressure modulation. 384 
In 15 subjects treated with anti-hypertensive medication, the attenuation found in oral nitrate 385 
reducing capacity after daily use of chlorhexidine mouthwash for 3 days was associated with an 386 
increase in systolic blood pressure of 2.3 mmHg, but only a trend for a decrease in plasma nitrite 387 
concentrations compared with the control (tap water)77. The lack of a significant effect on the 388 
plasma nitrite response relative to Kapil et al41 was thought to be due to the study visit being 389 
performed 12 h after prior use of the mouthwash treatment or related to the age or medication use of 390 
the hypertensive participants. In order to determine the mechanism underlying the effects of dietary 391 
nitrate intake on blood pressure, plasma cGMP, a mediator of NO-dependant smooth muscle 392 
relaxation in the endothelium and a good marker of NO production, can be measured. Although 393 
increases in plasma nitrite and cGMP after dietary nitrate intake have been previously associated 394 
with blood pressure lowering, no effects were evident on cGMP concentrations after 3 days of using 395 
mouthwash. This may be related to the lack of a nitrate challenge on the study visit (which provides 396 
an important source of NO under hypoxic conditions) but could also suggest that dietary nitrate may 397 
impact on vascular tone via direct effects on smooth muscle function.  398 
In contrast to these two studies, Tribble et al 78reported use of chlorhexidine mouthwash 399 
twice daily for 7 days to be associated with a highly variable effect on clinic systolic blood pressure 400 
(an increase of at least 5 mmHg found in n=9 subjects whereas a decrease was observed in n=4) in 401 
an orally healthy cohort. Post-hoc data analysis revealed the inclusion of tongue cleaning as part of 402 
the daily dental hygiene routine to play a significant role in the responses observed both on blood 403 
pressure and the diversity of the oral bacteria at baseline and during the study. Specifically, regular 404 
tongue cleaning was associated with a greater ability to reduce nitrite to NO whereas the lack of 405 
tongue cleaning resulted in an oral microbiome composition which favoured conversion of nitrite to 406 
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ammonia and not NO. The authors speculated the use of chlorhexidine mouthwash was having a 407 
chemo-stimulatory effect on the oral bacteria, with the temporary loss of bacterial numbers 408 
proposed to stimulate a rapid population recovery and increase in bacterial nitrate reductase activity. 409 
However, these effects may also reflect a protective upregulation of the nitrate, nitrite and NO 410 
regulating mechanisms in the microbiota suddenly detached from their biofilms during tongue 411 
cleaning and warrants further investigation.  412 
 In a cross-over study, treatment with chlorhexidine (0.2%) for 3 days was shown to have no 413 
effect on clinic or 24 h ambulatory blood pressure in 17 young females compared with a placebo 414 
mouthwash 79. Although a reduction in salivary nitrite and oral nitrate reducing capacity was found 415 
after the antibacterial mouthwash, comparable changes were not evident in either the plasma or 416 
urine samples collected. The lack of effects observed relative to other studies may reflect the short 417 
intervention time with the mouthwash treatments or inclusion of female participants only. Based on 418 
a previous study conducted by the same research group in athletes, they speculated that cross-talk 419 
may exist between the enterosalivary nitrate-nitrite-NO pathway and eNOS, with a greater intake of 420 
dietary nitrate associated with a lower eNOS activity. However, whether a reduction in nitrate-421 
nitrite-NO with antibacterial mouthwash leads to an upregulation in eNOS is yet to be established. 422 
In the studies presented in Table 3, measures of blood pressure have been related to salivary 423 
and plasma nitrate/nitrite levels following nitrate intake and use of mouthwash. In agreement with 424 
previous findings, Woessner et al 30 found antibacterial mouthwashes to attenuate postprandial 425 
salivary and plasma nitrite concentrations following dietary nitrate intake (concentrated beetroot 426 
juice) compared with the weaker antiseptic mouthwash and control. Although changes in clinic 427 
systolic blood pressure 0-3 h after the treatments were not related to plasma/salivary nitrite or 428 
nitrate levels, systolic blood pressure at 4 h was 2-5 mmHg higher after Chlorhexidine and Cepacol 429 
mouthwashes compared with control and Listerine mouthwash. These findings potentially suggest 430 
an important role of the nitrate-nitrite-NO enterosalivary pathway, but should be interpreted with 431 
caution due to the small sample size, inclusion of male subjects only and the short duration of the 432 
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study visit relative to the expected peak in plasma nitrite concentrations (approximately 3 h). 433 
Furthermore, these findings may have been influenced by the large inter-individual variability 434 
observed in blood pressure responses following the mouthwash treatments. 435 
 In the study of McDonagh and co-workers 80, consumption of 2 x 70 ml shots of 436 
concentrated beetroot juice and daily use of strong or weak antibacterial mouthwash for 6 days were 437 
found to have limited effects on baseline blood pressure and salivary and plasma nitrate/nitrite 438 
levels compared with the control (water). However, differences were evident 2-4 h after drinking 439 
the beetroot juice, with the rise in plasma nitrite found to be attenuated after use of the strong and 440 
weak mouthwash for 6 days. These changes were associated with a reduced oral nitrate reducing 441 
capacity after the strong mouthwash, with lower nitrite levels compared with both the weak and 442 
placebo mouthwashes. Although changes in resting measures of blood pressure (supine and seated) 443 
and pulse wave analysis (arterial stiffness) after the juice were not influenced by the strength of the 444 
mouthwash used, differences were evident in blood pressure during low-intensity activity on the 445 
treadmill. In particular, there was a greater increase in systolic blood pressure and mean arterial 446 
pressure after rinsing with the strong (Chlorhexidine) compared with the control (water) 447 
mouthwash. The lack of effect on arterial stiffness even in the presence of lower salivary and 448 
plasma nitrite levels after the strong mouthwash indicates that either the availability of NO was not 449 
altered sufficiently over the 4 h acute test period in these young active participants or that their 450 
higher physical active level may have masked any effects of the mouthwash on the vascular 451 
function measures. However, this is one of the only studies to incorporate a measure of blood vessel 452 
elasticity to determine the role of oral bacteria in mediating the beneficial effects of beetroot juice 453 
on vascular function, and so further studies are needed in which to compare these findings and 454 
determine the underlying mechanisms. 455 
As highlighted in the human studies, oral bacteria composition appears to vary between 456 
individuals, with both non-modifiable (e.g. age, sex, genetics and tongue physiology) and 457 
modifiable (e.g. diet, health conditions, life style and dental hygiene routine) factors considered to 458 
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impact on the abundance and prevalence of nitrate reducing bacteria in the oral cavity. These factors 459 
are important to consider during interpretation of the study findings and for informing the design of 460 
future studies exploring the role of oral nitrate reducing bacteria on the regulation of vascular 461 
function. The following section summarises the main factors identified from the human studies.  462 
 463 
Intra-individual variability in number and composition of oral bacteria  464 
Non-modifiable factors  465 
Geographical location and culture have all been suggested to impact on oral bacteria composition. 466 
Findings from a study including participants from Northern and Southern Europe, reported a higher 467 
abundance of Rothia and unclassified Gemellaceae in Finnish populations compare to Spanish 468 
while Lactococcus, Fusobacterium and Porphyromonas genus were significantly higher in Spanish 469 
compare to Finnish groups81. Comparing findings of this study with another study which 470 
investigated the differences in oral bacteria between people living in Africa, Alaska and Germany 471 
showed that oral bacteria composition is highly variable between countries82. These differences may 472 
represent the sex and age distributions of these different populations, genetic make-up and habitual 473 
food preferences83’82.  474 
Moreover, the dorsal surface of the tongue plays a major role in nitrate reduction and 475 
represents a highly papillated surface area. The papillary structure of the human tongue is unique in 476 
nature and supports a higher bacterial density than the mucosal surface, accumulating oral debris 477 
and anaerobic bacteria on the rear of tongue42. There are three kinds of papillae on the tongue: 478 
fungiform, circumvallate and foliate papillae. The fungiform papillae have a mushroom shape and 479 
are found predominately on the dorsal surface of the tongue covering up to two-thirds of the 480 
surface. Their shape supports a higher bacterial density84. However, the shape and number of 481 
papillae varies between individuals which has been related to differences in oral bacteria 482 
composition. Studies have shown that a number of factors can affect the papillary number on the 483 
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tongue including ageing (with lower number of papillae observed in those individuals over 60 484 
years), genetic make-up, ethnicity81, demographics and environment84. 485 
Within the oral cavity, the presence of teeth increases the bacterial density compared to 486 
those with permanent tooth loss since the gingival crevices between teeth represent a greater surface 487 
area and environment for bacterial growth85. Other important factors considered to impact on the 488 
variety of nitrate reduction bacteria present in the oral cavity are ageing and sex. However, in a 489 
recent human study conducted in n=9 participants < 22 years and n=9 > 70 years, a similar salivary 490 
microbiome at baseline and after placebo beetroot juice was found in both groups. Comparable 491 
changes in bacterial composition (increases in Rothia and Neisseria) were also evident in both age 492 
groups in response to consuming 70 ml of beetroot juice ( 6.2 mmol nitrate) daily for 10 days86 493 
suggesting that age was not an important modulator of the oral bacteria composition in this study. 494 
Few studies have determined differences in oral bacteria composition between men and women. In 495 
order to address this knowledge gap, Kapil and colleagues87 examined the impact of sex on nitrate 496 
reducing bacteria abundance in 13 male and 13 females age 18-45 years. Oral bacteria samples were 497 
collected before and after nitrate supplementation and all samples were analyzed by 16S rRNA 498 
sequencing. Significant sex dependent effects on oral nitrate reducing bacteria composition were 499 
not found in this study. However, sub-group analysis indicated females to have a non-significant 500 
tendency for a higher activity of nitrate reducing bacteria than men87’74 but these findings need to be 501 
confirmed in a suitably powered study. 502 
 503 
Modifiable factors 504 
Several modifiable factors have been reported to influence and change the oral nitrate reducing 505 
bacteria composition, with dietary nitrate intake considered to be one of the most important 506 
factors27’88. In a recent cross-over study conducted in 18 volunteers assigned to receive a nitrate 507 
supplement or a placebo for 10 days, an increase in the abundance of some nitrate reducing bacteria, 508 
particularly Rothia and Neisseria was linked with the ability of an individual to reduce the nitrate 509 
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supplement. However, changes were not observed with the Prevotella and Veillonella species86. 510 
Interestingly, these results corroborate findings from another study which reported the reduction in 511 
Prevotella and Veillonella species in the oral cavity of elderly adults following dietary nitrate intake 512 
to be associated with a lower mortality risk in this population88. Furthermore, the increased 513 
prevalence of Rothia and Neisseria species relative to the Prevotella and Veillonella species was 514 
linked to higher NO bioavailability in both saliva and plasma86. These findings imply that the oral 515 
bacteria community is responsive to changes in the level of dietary nitrate intake89. However, the 516 
authors also reported that individuals with a higher abundance of Campylobacter concisus and 517 
Prevotella melaninogenica in their oral cavity at baseline may not be as responsive to dietary nitrate 518 
intake than those with a lower proportion of these bacteria86. This might reflect the fact that both 519 
Campylobacter. concisus and Prevotella. melaninogenica are predominately nitrite, but not nitrate, 520 
reducers in the oral cavity. Therefore, dietary nitrate availability may affect the growth and 521 
composition of particular groups of oral bacteria which can be related to improved cardiovascular 522 
health89. Of particular note, drinking beetroot juice rich in dietary nitrate can increase the oral cavity 523 
pH from 7.0 to 7.5 which is close to the optimal pH of 8 required for nitrate reductase activity90. 524 
Therefore, the effect of pH is also important in terms of the proliferation and inhibition of different 525 
populations within the oral bacterial community86.  526 
In a similar fashion, some health conditions have also been reported to influence the oral 527 
bacterial composition, with a lower density of nitrate reducing bacteria and a different bacterial 528 
composition found in people with raised blood pressure (hypertensives) than normotensive 529 
subjects31. A recent novel study has provided further evidence on the relationship between 530 
differences in oral bacteria composition with hypertension in postmenopausal women (n=446). This 531 
study analysed oral bacterial samples by using 16S RNA sequencing and found that the abundance 532 
of Prevotella oral species 317 and Streptococcus oralis were significantly lower in women with 533 
elevated blood pressure compared with those with normal blood pressure91. Furthermore, the 534 
differences in the oral bacteria communities between groups also seemed to be associated with the 535 
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severity and progression of the hypertension 33. Conversely, a higher abundance of nitrate reducing 536 
bacteria were observed in individuals who suffer from migraines (a vascular driven process 537 
associated with changes in NO). Interestingly, the dominant nitrate reducing bacteria in these 538 
individuals were Pseudomonas and Streptococcus which are not common in subjects who did not 539 
suffer with migraines. Oligotyping (the technique for differentiation between closely related 540 
microbial taxa)92 was performed for both genera to investigate the strain-level differences across the 541 
bacterial population. Pseudomonas decompose to 2 oligotypes (different strains of the same 542 
species) and has differential abundance patterns with significantly higher abundance in oligotype 2 543 
in those suffering from migraines compared with non-sufferers93. These results suggest that the type 544 
of these oral bacteria may be more prevalent in people with migraines. However, more work is 545 
needed to find the link and the mechanism to explain how these bacteria adapt genetically to their 546 
host environment.  547 
Therefore, there may be an optimum number and composition of nitrate reducing bacteria 548 
which has beneficial effects, and a greater level may have a negative impact on conditions 549 
associated with blood vessel dilation such as migraine. However, it should be acknowledged that 550 
nitrate reduction and metabolism cannot be attributed to single bacterial species as they are unlikely 551 
to express all of the enzymes required to decompose nitrate simultaneously. More likely, these 552 
individual nitrate reducing bacteria are considered to work in synergy with other members of the 553 
microbial community. This has been demonstrated by Hyde et al, 43 who found that mixed colonies 554 
of high and low nitrate reducers showed a greater capacity for nitrate reduction than mixes of either 555 
multiple high reducers or individual nitrate reducing bacteria. This highlights the complexity of the 556 
oral microbiome and the impact on dietary nitrate metabolism. 557 
Cardiometabolic diseases including obesity, the metabolic syndrome and type II diabetes are 558 
major contributors to global CVD disease burden. Whilst some studies have reported plasma 559 
nitrate/nitrite levels to be negatively associated with waist circumference 94, obesity 95 and blood 560 
pressure, others have observed positive associations between plasma nitrite and BMI, fasting blood 561 
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glucose 96, systolic blood pressure and the fasting lipid profile. In support of these findings, Akram 562 
et al (2018)97, found plasma nitrite levels to be higher in individuals with both obesity and the 563 
metabolic syndrome followed by those with obesity alone, with the lowest levels in those with 564 
normal weight. Whether high plasma nitrite levels play a role in the worsening of the 565 
cardiometabolic risk markers is a public health issue since higher dietary nitrate intakes may also 566 
cause higher levels of plasma NOx (sum of nitrate and nitrite levels). Furthermore, these data are 567 
associations, do not indicate whether cardiometabolic risk markers change in response to varying 568 
nitrate/nitrite intakes and do not prove cause and effect. Interestingly, a review of the evidence 569 
suggests the contrary, with dietary nitrate supplementation found to reverse or improve some of the 570 
features of the metabolic syndrome and be protective against the development of CVD98. Although 571 
these beneficial effects may be related to improvements in NO metabolic pathways and glucose 572 
control, we cannot discount that favourable changes in the gut microbiota in response to dietary 573 
nitrate intake may also represent an important mechanism since dysbiosis (a term to describe 574 
microbial imbalance) is a common feature of the cardiometabolic diseases. However, very few 575 
studies have determined the impact of dietary nitrate supplementation on the gut microbiota in 576 
humans, with a very short-term study with nitrate-rich fruit and vegetable juice suggesting a 577 
reduction in the Firmicutes to Bacteroides ratio after 3 days which was related to higher plasma 578 
nitrate/nitrite levels 99. Furthermore, a one-year intervention with the Mediterranean diet, rich in 579 
vegetables, was associated with increased abundance of specific taxa that were inversely associated 580 
with inflammatory markers 100. More studies are needed to address this research gap which also 581 
include analysis of the oral microbiome to determine whether increases in the abundance of nitrate 582 
reducing bacteria are related to improvements in cardiovascular health.    583 
Oral hygiene habits, including daily use of an antibacterial mouthwash or tongue scraper 584 
have been found to not only reduce acute bacterial infection, but also numbers of bacteria present30. 585 
On the other hand, poor oral hygiene contributes to dysbiosis by accumulating a plaque biofilm 586 
which contains large number of microbes including nitrate reducing bacteria 101. This can cause 587 
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dental infections and gingivitis by increasing pathogenic bacteria such as (porphyromonas 588 
gingivalis)102. Studies have shown that patients with periodontal disease to have higher levels of 589 
salivary nitrite which may be partly derived from the reduction of nitrates by the oral bacteria. Since 590 
nitrite has been shown to have an antimicrobial effect against gastrointestinal and oral pathogens, it 591 
has been speculated that the salivary glands may respond to the periodontal infection by enhancing 592 
the secretion of nitrate and production of nitrite by the nitrate reducing bacteria as a host defence 593 
mechanism103. This is thought to reduce the prevalence of the acidogenic bacteria which contribute 594 
to the development of dental caries. In agreement, Doel et al 42 has reported a significant reduction 595 
in dental carries in study participants with high salivary nitrate concentration. Epidemiological 596 
studies have reported an association between periodontal disease with CVD. Although the cause 597 
and effect relationship has not been proven, studies have suggested that inflammation caused by the 598 
oral infection may contribute to the development and progression of the atherosclerotic plaque. 599 
Interestingly, periodontal pathogens have been identified in the atherosclerotic plaque suggesting a 600 
direct role in CVD. However, to date, periodontal disease has not been considered to be a CVD risk 601 
marker104. Lifestyle habits such as smoking can also influence oral bacteria composition74. In a 602 
study conducted in 9 non-smokers aged 20-45 y and n=5 healthy active smokers (>20 cigarettes per 603 
week) aged 30-60 years, nitrate reduction activity was found to be over 80% lower in smokers 604 
compared to non-smokers74. However, the low numbers of individuals within each group may have 605 
influenced the results observed. 606 
As previously mentioned, dietary nitrates have been shown to interact with other food 607 
components such as lipids72, with similar reports for polyphenols105, alcohol106 and proteins 25. In 608 
particular, foods and beverages rich in polyphenols including apple, tea and orange juice have been 609 
shown to lead to a 3 fold increase in NO production in the stomach107 and reduce endogenous N-610 
nitrosamine formation. Along with polyphenols, the content of ethanol in red wine can also interact 611 
with nitrite forming ethyl nitrite which works as a nitrosation agent and may mediate NO effects. 612 
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These interactions with other dietary components may therefore play a role in modulating the 613 
circulating NO levels and bioavailability of the nitrate and nitrite contained within foods. 614 
In summary, a systematic approach was used to identify the studies that have determined the 615 
impact of oral bacteria on blood pressure in response to nitrate intake, from dietary sources or 616 
supplements. However, only a very limited number of human (n=2) and animal (n=3) studies have 617 
addressed this research question, with the remaining studies examining the importance of the oral 618 
bacteria on the nitrate reducing capacity on circulating nitrite concentrations and blood pressure. 619 
Based on our observations from these studies, there is accumulating evidence to suggest that 620 
absence of nitrate-reducing oral bacteria was associated with increasing blood pressure even when 621 
accompanied by a high nitrate intake. However, some of the studies failed to see any effects, which 622 
may be due to type of mouthwash used in the human studies or the method of application of the 623 
mouthwash in the animal study29. Sex, hypertension, and tongue cleaning were all found to be 624 
important potential determinants of the variability in the responses between participants. Of these, 625 
the dental hygiene practice of tongue cleaning, which is recommended by the American Dental 626 
Association, appeared to promote oral microbiota diversity and be associated with a greater ability 627 
to recover the tongue microbiome after mouthwash use. Potential mechanisms to explain the blood 628 
pressure lowering effects of dietary nitrates included increases in plasma nitrite, S-nitrosothiols, 629 
nitro-fatty acids and vascular nitrosylation and cross-talk between the enterosalivary nitrate-nitrite-630 
NO pathways and eNOS activity in the endothelial cells. However, the limited number of studies 631 
performed make it difficult to draw any firm conclusions from this literature review. 632 
 633 
Conclusions 634 
With the increasing prevalence of non-communicable diseases there is an urgent need for further 635 
studies to investigate the role of the oral bacteria on cardiovascular health in response to dietary 636 
nitrate intake, and to determine the underlying mechanisms. With vascular function now recognised 637 
as an important prognostic marker for future CVD risk, studies incorporating real time measures of 638 
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vascular reactivity and tone are required. Furthermore, the use of rigorous methods to determine 639 
changes in the abundance and composition of the oral bacteria in response to intake of dietary 640 
nitrate would help to identify important nitrate-reducing bacteria related to changes in vascular 641 
function and determine whether these bacterial groups are also evident in the gut microbiome, a 642 
proposed modulator of chronic disease risk. Diets containing nitrate-rich foods may contain other 643 
bioactive components which could also contribute to CVD risk reduction, including fibres, 644 
vitamins, minerals and flavonoids. Such diets may offer a number of advantages over nitrate/nitrite 645 
supplemental use, not only due to the availability of  other bioactive components, but also because 646 
of reports of vascular adaptation and risk of marked acute hypotension after supplemental nitrate 647 
use, not found with nitrate-rich diets108. With hypertension a major risk factor for CVD, more 648 
studies are needed to determine whether diets higher in nitrate-rich foods can be recommended for 649 
blood pressure lowering and disease prevention in healthy individuals and those at greater CVD 650 
risk.  651 
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Tables 
Table1: Commonly reported nitrate reducing bacteria species found in the oral cavity  
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Table 2: Animal studies investigating the importance of oral nitrate reducing bacteria on blood pressure in response to nitrate intake. 
Reference Animals Study design and duration Intervention Measurement Outcome measures 
Petersson 
200970 
n= 4-7 Male Sprague 
Dawley rats each 
group (190-360 g, B 




Parallel groups with 7 day 
treatment periods: 
1) No treatment (control). 
2) NaNO3 only  
3) Mouthwash 
4) Mouthwash + NaNO3 
or NaNO2 
Water supplemented with 





spray (0.3 ml), 2X daily. 
Plasma 
 
∆ NO2 ↓ after mouthwash + 










↓after NaNO3. DBP lowering 









↓ after NaNO3 and 
mouthwash + NaNO2 vs 
mouthwash only. MAP 
lowering absent in 
mouthwash + NaNO3 rats 
 




n= 8 Male Wistar rats  
7 weeks old 
19 day sequential intervention:  
0-5 control (water) 
6-12 NaNO3,  
13-19 NaNO3 + mouthwash 
 
Blood collected at day 1, 5, 6, 
12, 13 & 19. BP (telemetry) 
and tongue swab every day 
NaNO3 (1 g/L) in drinking 
water 
 
Mouthwash regime: 0.3 ml 
of chlorohexidine applied 
2X daily to tongue dorsal 







↓ after NaNO3 and 
mouthwash + NaNO3 vs 
control  
 
Plasma NOx NS 




n = 10, Male Wistar 
rats each group (190-
210 g) 
 




Sham operated control 
group 
6 weeks – 2 weeks baseline 






Mouthwash + NaNO2  
 




Mouthwash + NaNO3 
 
6 h after last treatment, blood 
and tongue swab collected. 
 
15 mg NaNO2/kg or 140 
mg NaNO3/kg (gavage) 
 
Mouthwash groups: Daily 






∆ NO2 ↓ 25–30% after 
mouthwash vs NaNO2 and 
NaNO3 groups (P < 0.05) 
∆ NO3 ↓ 45% after 
mouthwash vs NaNO2 group 










↓ SBP (40 mmHg) and MAP 
with NaNO2 and NaNO3 (P= 
0.01). 
Mouthwash blunted MAP 
and SBP lowering effect of 
NaNO3 (p <0.05) but not 
NaNO2  
 
↓CFU 50-70% with 
mouthwash 
 
Abbreviations: DBP: Diastolic Blood Pressure, HR: Heart Rate, MAP: Mean Arterial Pressure, NS: Not Significant, NO2: Nitrite Concentration, SBP: 
Systolic Blood Pressure, NO3: Nitrite Concentration, CFU: Colony Forming Unit (number of viable bacteria)
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Table 3: Human studies determining the effects of oral bacteria on salivary and plasma nitrite concentrations, and/or blood pressure in 









al., 2017 75 
n=12 (6M/6F) 
Normotensive, 
Age 19-44 y 
Non-smoking,  
Acute, RCT, CO 
4 visits 10 h in duration with 
1 wk washout. 
 
Saliva and oral bacteria 
collected 0, 1 and 10 h. 
100 g lettuce 
(110 mg NO3) 
with breakfast. 
Lunch at 5 h. 
1. Water (control) 





Treatment for 3 min 








Relative to baseline: 
 NO3 and NO2 
after each treatment 
(P < 0.05) 
 
↓ nitrate reducing 
bacterium V. Dispar 







BMI 23 kg/m2  
Non-smoking  
Acute, RCT, CO 
2 visits of 3 h in duration. 
 
Blood and saliva samples 
collected before and for 3 h 
after nitrate intake. 
Oral bacteria collected in n=4 
after mouthwash only. 
10 mg/kg 
NaNO3 in 100 
ml water 





twice for 1 min, 15 min 
before nitrate ingestion. 
Saliva  ↑NO3 on both visits 






Oral bacteria  
NO3 ↓ 29 nM and 
NO2 ↓ 250 nM at 3 
h vs no mouthwash 
 
↓ bacteria count and 
(80%) and nitrate 
reducing capacity 
after mouthwash. 
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Woessner 
et al 201630 
n=12 (M)  
Normotensive 
𝑥 age 36 y and 




Acute, RCT, CO 
4 visits, 4 h in duration with 
1 wk washout. 
 
BP, blood and saliva 
collected before and for 4 h 
after juice consumption 





1) Water (control) 






Treatment 15 min after 






↓ Listerine and 
control vs Cepacol 
and Chlorhexidine 












↑ NO3 all treatments 
↑ NO2 control vs all 
mouthwashes and ↓ 
NO2 Chlorhexidine 
and Cepacol vs 
antiseptic (P ≤0.05) 
Plasma  ↑ NO3 all 
treatments 
↓ NO2 
Chlorhexidine vs all 
treatments and 
Cepacol vs control 
(P ≤0.05) 
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Bondonno 
et al 201276 
N=16 F 
Normotensive 




Acute, RCT, CO 
5 visits of 3 h in duration. 
1 wk washout. 
Blood and saliva samples 
collected before and for 3 h 
after nitrate intake 
0, 100, 200, 













↑ NO3 all treatments 
 
 
↑ NO3 all treatments 
 
ACUTE WITHIN CHRONIC 
McDonagh 
et al 2016 80 
n=12 (6M/6F) 
Normotensive 
𝑥 age 22±2y (F) 
and 24±2 y (M). 
Non-smokers,  
 
Acute within chronic, RCT, 
double blind 
6 visits over 8 weeks 
Each treatment 6 days, with 
acute visits (4 h) on days 0 
and 6. 
 
Acute visits: Rinse with 
mouthwash 15 min before 
ingesting 2 x 70 ml beetroot 
juice. Measurements at 0, 2 
and 4 h. BP and PWA 
measured at rest and during 
10 min of treadmill walking. 
Saliva and plasma samples 
collected. 
70 ml of 
beetroot juice 
(6.2mmol 
nitrate) twice a 
day 
1) Strong - Corsodyl 
(Chlorhexidine)  




3) Deionised water (con) 
3X daily 15 mins before 
beetroot juice and meals, 
























Relative to baseline 
(0 h): 
Resting - NS 
After 10 min 
exercise, ↑ 3 mmHg 
after strong 
mouthwash vs 
control (P = 0.07) 4 
h after beetroot 
juice 
Resting and during 
exercise – NS 
Resting - NS 
After 10 min 
exercise, ↑ after 
strong mouthwash 
vs control (P<0.05) 
at 4 h. 
During exercise ↑ 
after strong vs 
control and weak 
(P<0.05).  
NS 
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↑NO3 all treatments 
∆ NO2 ↓ after 
strong vs other 
treatments at 2 and 
4 h, and weak vs 
control (P<0.05) at 
2 h 
∆ NO3 ↑ and ∆ 
NO2 ↓ after strong 
vs weak and control 
(P<0.05) at 4 h. 
 
Abbreviations: DBP: Diastolic Blood Pressure, HR: Heart Rate, MAP: Mean Arterial Pressure, RCT: Randomized Controlled Trial, NS: Not 
Significant, PWA: Pulse Wave Analysis, SBP: Systolic Blood Pressure, CO: Cross Over. 
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Age 22-71 y 
 
Sequential  
4 visits over 14 days:  
days 1 (baseline), 7 (post 
mouth wash), 10 
(recovery) and 14 
(recovery) 
 
Clinic BP and oral 
bacteria at each visit. n=6 
oral nitrate reducing 
capacity for 8 h after 30 s 
mouthwash 
Mouth rinse 
with 1 mM 
NaNO3 for 2 
min 
Chlorhexidine (0.12%) 












In response to mouthwash, 




↓ Species diversity and 
abundance with 
mouthwash for 7 days. ↑ 
bacterial metabolic activity 
at day 14. 
↓ NO3:NO2 ratio for 6-8 h 
after mouthwash. 
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Sunqvist et 
al 2016 79 
n=17 (F)  
Normotensive 
𝑥 age 23 y  
BMI = 22 
kg/m2  
Non-smoking. 
RCT, CO, double blind 
Each treatment 3 days 
with a 28 day washout 
4 visits (days 3 and 4 of 
each treatment)  
 
24 h ABP and urine 
sample. 
Clinic BP, saliva and 
plasma samples and oral 
nitrate reducing capacity 
Mouth rinse 
with 10 mM 
NaNO3 for 5 
min 
Chlorhexidine (0.2%) or 
placebo mouthwash  
3 x daily after meals for 
60s.  
BP No difference in ABP or 
clinic BP 
Saliva ↑ NO3 and ↓ NO2 after 








No change in NO3 and 
NO2 with mouthwash vs 
placebo 
excretion of NO3 with 
mouthwash vs placebo 
↓NO2 after mouthwash (8 
µM) vs placebo (234 
µM)(P<0.001) 
Bondonno 
et al 2015 77 





Each treatment 3 days 
with a 10-12 day washout. 
 




Chlorhexidine or tap 
water 
(control) 
SBP ↑ 2.3 mmHg after 
mouthwash vs water (P= 
0.01) 
DBP NS 









Visits at day 0 and 3 of 
each treatment. 
 
Saliva sample, oral nitrate 
reducing capacity and 
plasma sample. BP 
measured at home. 
2x daily with 20 ml for 











↑ NO3 and ↓NO2 after 
mouthwash vs control (P= 
0.001) 
↓ NO2 after mouthwash vs 
control (P= 0.09). NO3 - 
NS 
↓ nitrate reductase ratio 
after mouthwash 










reported use of 
Sequential  
2 visits (0 and 14 days).   
 
At each visit, clinic BP, 
blood, urine and saliva 
samples and oral nitrate 




3 doses of 
KNO3 (0, 0.8 
and 80 µmol) 
in the mouth 
for 5 min. 
Chlorhexidine (0.2%) 




Relative to baseline, use of 
mouthwash 
↑ 3.5mmHg (P = 0.003) 
Clinic DBP ↑ 2.2mmHg (P = 0.038) 
A-SBP 




↑2.4 mmHg (P= 0.017) 
↑2.2 mmHg (P= 0.014) 
↑2.9 mmHg (P< 0.001) 
↑2.0 mmHg (P< 0.001) 
NS 




Fitted with ABP unit for 











↑NO3 and ↓NO2 90% (P< 
0.001) 
↑NO3 and ↓NO2 25% (P= 
0.001) 
↑NO3 and ↓NO2 
 
At baseline, NO2 in mouth 
rinse dose dependent 
(0<0.8<80 µmol KNO3) 
After mouthwash, ↓ 90% 
NO2 in mouth rinse for 0.8 
and 80 µmol KNO3.  
Abbreviations: DBP: Diastolic Blood Pressure, HR: Heart Rate, MAP: Mean Arterial Pressure, RCT: Randomized Controlled Trial, NS: Not 
Significant, PWA: Pulse Wave Analysis, SBP: Systolic Blood Pressure, CO: Cross Over, ABP: Arterial Blood Pressure 
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FIGURE LEGENDS 
Figure 1: Diagram of the endogenous generation of nitric oxide (NO) by NO synthase (NOS) (right 
panel highlighted in pink), and exogenous generation of NO from the diet (left panel highlighted in 
blue)28. In biological fluids, NO is oxidized to nitrite (NO2) and nitrate (NO3) (dashed arrows). 
 
Figure 2: Overview of the nitrate enterosalivary circulation and nitrate metabolism in humans. 
Ingested inorganic nitrate is converted to nitrite in the oral cavity by nitrate reducing bacteria with 
reduction to NO and nitrogen oxides occurring within the acidic environment of the stomach. 
Remining nitrate and other nitrate components are then rapidly absorbed into the bloodstream via 
the small intestine. A large proportion of nitrate is then excreted by the kidneys into the urine, with 
up to 25% being recycled by the salivary glands and then concentrated in saliva. 
 
Figure 3: Flow of information through the different phases of the literature review   
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NO2 in blood 
stream for       
5 – 6 hr 
70 – 75% of NO3 
excreted in urine 









NO2 to NO 






NO3 to NO2 
in oral 
cavity 
80% of dietary nitrate 
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FIGURE 3  
 
 
97 excluded  
Removal of duplicates 
Not published in English 





























Studies included in this review 
 (n = 12) 
Studies identified from searching 
database 
 (PubMed and Web of science) 
(n =160) 
Full text and potential relevant papers 
identified and screened for eligibility 
(n =63) 
34 excluded based on title,  
19 excluded based on abstract and 
full text publication 
Human 
(n=9) 
Animal 
(n=3) 
